BG
Bollard Group Portfolio holdings
AUM
$4.04B
1-Year Est. Return
15.82%
1 Year Est. Return
+15.82%
AUM
$4.04B
AUM Growth
-$176M
(-4.2%)
Holding
298
Top Buys
| 1 | +$5.85M | |
| 2 | +$5.44M | |
| 3 | +$3.92M | |
| 4 |
Oneok
OKE
|
+$3.7M |
| 5 |
Enterprise Products Partners
EPD
|
+$3.63M |
Top Sells
| 1 | +$33.8M | |
| 2 | +$33.7M | |
| 3 | +$16.6M | |
| 4 |
BioNTech
BNTX
|
+$2.75M |
| 5 |
Entegris
ENTG
|
+$1.85M |
Sector Composition
| 1 | Healthcare | 53.91% |
| 2 | Technology | 7.72% |
| 3 | Energy | 7.68% |
| 4 | Utilities | 5.26% |
| 5 | Consumer Discretionary | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
276
Entegris
ENTG
$15.8B
| – | – |
-22,947
|
|
||
277
Elastic
ESTC
$7.64B
| – | – |
-16,924
|
|
||
278
Flywire
FLYW
$1.75B
| – | – |
-25,609
|
|
||
279
Fortive
FTV
$17.7B
| $0 | ﹤0.01% |
3
|
|
||
280
Insmed
INSM
$34.9B
| – | – |
-17,191
|
|
||
281
Iovance Biotherapeutics
IOVA
$945M
| – | – |
-10,700
|
|
||
282
Disc Medicine
IRON
$2.91B
| – | – |
-30,635
|
|
||
283
Kenvue
KVUE
$32.8B
| $0 | ﹤0.01% |
15
|
|
||
|
MZTI
284
The Marzetti Company
MZTI
$4.67B
| – | – |
0
|
|
||
285
Nice
NICE
$7.1B
| – | – |
-4,974
|
|
||
286
Northern Oil and Gas
NOG
$2.24B
| – | – |
-589
|
|
||
287
Nurix Therapeutics
NRIX
$1.93B
| – | – |
-122,782
|
|
||
|
OLO
288
DELISTED
Olo Inc
OLO
| – | – |
-9,510
|
|
||
289
Omnicell
OMCL
$2.28B
| $0 | ﹤0.01% |
1
|
|
||
290
PagerDuty
PD
$1.1B
| – | – |
-94,658
|
|
||
291
Revvity
RVTY
$12.6B
| – | – |
-18,439
|
|
||
292
Solid Biosciences
SLDB
$453M
| – | – |
-361,660
|
|
||
293
Tenable Holdings
TENB
$2.69B
| – | – |
-34,277
|
|
||
294
Tyler Technologies
TYL
$19.4B
| – | – |
-1,462
|
|
||
295
Vera Therapeutics
VERA
$3.44B
| – | – |
-64,042
|
|
||
296
Viatris
VTRS
$15.1B
| $0 | ﹤0.01% |
29
|
|
||
297
Wayfair
W
$14.9B
| – | – |
-25
|
|
||
298
Whirlpool
WHR
$4.79B
| – | – |
-47
|
|